Ashish Manne, Associate Professor at Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute, shared on LinkedIn:
“Thrilled to share that I’ll be speaking at the PANCAN Scientific Summit 2026!
I’ll be presenting two lines of original work from our program at The Ohio State University Comprehensive Cancer Center – The James that tackle that gap from different angles:
AI-driven digital pathology for molecular subtyping: Using routine H&E slides, which every patient already has, to infer molecular tumor features that currently require costly, time-consuming testing. The goal is to make molecular insight accessible at the point of diagnosis.
MUC5AC in pancreatic cancer: Our multi-cohort translational work on MUC5AC expression and what it may tell us about tumor biology, prognosis, and treatment response.
Both projects reflect what I care about most: turning what we already collect into information that changes decisions for patients.
I’m grateful to my collaborators, trainees, and the patients and families whose samples and trust make this research possible. And thank you to PANCAN for building a community where science moves with urgency.”
Other articles featuring Ashish Manne on OncoDaily.